vs
Side-by-side financial comparison of Emerald Holding, Inc. (EEX) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Emerald Holding, Inc. is the larger business by last-quarter revenue ($132.7M vs $70.6M, roughly 1.9× Viridian Therapeutics, Inc.\DE). Emerald Holding, Inc. runs the higher net margin — -22.8% vs -49.0%, a 26.3% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs 24.3%). Emerald Holding, Inc. produced more free cash flow last quarter ($11.7M vs $-84.7M).
TVS Emerald Haven Realty Limited is an Indian real estate development company headquartered in Chennai, Tamil Nadu. A subsidiary of TVS Holdings, it specializes in sustainable residential communities and urban development projects.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
EEX vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $132.7M | $70.6M |
| Net Profit | $-30.2M | $-34.6M |
| Gross Margin | — | — |
| Operating Margin | -11.8% | -56.7% |
| Net Margin | -22.8% | -49.0% |
| Revenue YoY | 24.3% | 81958.1% |
| Net Profit YoY | -692.2% | 54.9% |
| EPS (diluted) | $-0.15 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $132.7M | — | ||
| Q3 25 | $77.5M | $70.6M | ||
| Q2 25 | $105.5M | — | ||
| Q1 25 | $147.7M | — | ||
| Q4 24 | $106.8M | — | ||
| Q3 24 | $72.6M | — | ||
| Q2 24 | $86.0M | — | ||
| Q1 24 | $133.4M | — |
| Q4 25 | $-30.2M | — | ||
| Q3 25 | $-14.4M | $-34.6M | ||
| Q2 25 | $-1.4M | — | ||
| Q1 25 | $15.3M | — | ||
| Q4 24 | $5.1M | — | ||
| Q3 24 | $-11.1M | — | ||
| Q2 24 | $-2.8M | — | ||
| Q1 24 | $11.0M | — |
| Q4 25 | -11.8% | — | ||
| Q3 25 | -10.1% | -56.7% | ||
| Q2 25 | 9.7% | — | ||
| Q1 25 | 24.2% | — | ||
| Q4 24 | 19.5% | — | ||
| Q3 24 | -6.5% | — | ||
| Q2 24 | 7.4% | — | ||
| Q1 24 | 18.2% | — |
| Q4 25 | -22.8% | — | ||
| Q3 25 | -18.6% | -49.0% | ||
| Q2 25 | -1.3% | — | ||
| Q1 25 | 10.4% | — | ||
| Q4 24 | 4.8% | — | ||
| Q3 24 | -15.3% | — | ||
| Q2 24 | -3.3% | — | ||
| Q1 24 | 8.2% | — |
| Q4 25 | $-0.15 | — | ||
| Q3 25 | $-0.07 | — | ||
| Q2 25 | $-0.01 | — | ||
| Q1 25 | $0.08 | — | ||
| Q4 24 | $0.01 | — | ||
| Q3 24 | $-0.05 | — | ||
| Q2 24 | $-0.03 | — | ||
| Q1 24 | $0.00 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $100.9M | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $338.8M | $503.0M |
| Total Assets | $1.2B | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $100.9M | — | ||
| Q3 25 | $95.4M | $490.9M | ||
| Q2 25 | $156.4M | — | ||
| Q1 25 | $276.8M | — | ||
| Q4 24 | $194.8M | — | ||
| Q3 24 | $188.9M | — | ||
| Q2 24 | $193.2M | — | ||
| Q1 24 | $186.8M | — |
| Q4 25 | $338.8M | — | ||
| Q3 25 | $369.5M | $503.0M | ||
| Q2 25 | $389.4M | — | ||
| Q1 25 | $392.1M | — | ||
| Q4 24 | $385.9M | — | ||
| Q3 24 | $391.1M | — | ||
| Q2 24 | $407.6M | — | ||
| Q1 24 | $-90.7M | — |
| Q4 25 | $1.2B | — | ||
| Q3 25 | $1.2B | $577.1M | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | $1.0B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $12.3M | $-84.6M |
| Free Cash FlowOCF − Capex | $11.7M | $-84.7M |
| FCF MarginFCF / Revenue | 8.8% | -120.1% |
| Capex IntensityCapex / Revenue | 0.5% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $41.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.3M | — | ||
| Q3 25 | $1.8M | $-84.6M | ||
| Q2 25 | $15.9M | — | ||
| Q1 25 | $12.6M | — | ||
| Q4 24 | $20.6M | — | ||
| Q3 24 | $9.1M | — | ||
| Q2 24 | $9.8M | — | ||
| Q1 24 | $7.3M | — |
| Q4 25 | $11.7M | — | ||
| Q3 25 | $1.5M | $-84.7M | ||
| Q2 25 | $15.8M | — | ||
| Q1 25 | $12.4M | — | ||
| Q4 24 | $19.9M | — | ||
| Q3 24 | $9.0M | — | ||
| Q2 24 | $9.6M | — | ||
| Q1 24 | $7.0M | — |
| Q4 25 | 8.8% | — | ||
| Q3 25 | 1.9% | -120.1% | ||
| Q2 25 | 15.0% | — | ||
| Q1 25 | 8.4% | — | ||
| Q4 24 | 18.6% | — | ||
| Q3 24 | 12.4% | — | ||
| Q2 24 | 11.2% | — | ||
| Q1 24 | 5.2% | — |
| Q4 25 | 0.5% | — | ||
| Q3 25 | 0.4% | 0.2% | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.2% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.82× | — | ||
| Q4 24 | 4.04× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.66× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EEX
| Connections Segment | $121.9M | 92% |
| Commerce Segment | $5.5M | 4% |
| Content | $5.3M | 4% |
VRDN
Segment breakdown not available.
